Case Report: Unilateral Sixth Cranial Nerve Palsy Associated With COVID-19 in a 2-year-old Child.
COVID-19
SARS-CoV-2
anti-SARS-CoV-2 antibodies
pediatric
sixth cranial nerve palsy
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2021
2021
Historique:
received:
09
08
2021
accepted:
25
11
2021
entrez:
3
1
2022
pubmed:
4
1
2022
medline:
4
1
2022
Statut:
epublish
Résumé
Children have been described to show neurological symptoms in acute coronavirus disease 2019 (COVID-19) and multisystemic inflammatory syndrome in children (MIS-C). We present a 2-year-old boy's clinical course of unilateral acute sixth nerve palsy in the context of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Onset of the palsy in the otherwise healthy boy occurred seven days after symptoms attributed to acute infection had subsided respectively 3 weeks after onset of respiratory symptoms. SARS-CoV-2 specific IgG was detected in serum as well as in cerebrospinal fluid. The patient showed a prolonged but self-limiting course with a full recovery after three and a half months. This case illustrates in a detailed chronological sequence that sixth cranial nerve involvement may occur as post-infectious, self-limiting complication of pediatric SARS-CoV-2-infection thus expanding the neurological spectrum of symptoms for children with COVID-19. Clinicians should be aware of the possibility of post-infectious sixth nerve palsy related to SARS-CoV-2-infection particularly in view of recent respiratory tract infection or confirmed cases of SARS-CoV-2-infection amongst the patient's close contacts.
Identifiants
pubmed: 34976891
doi: 10.3389/fped.2021.756014
pmc: PMC8718702
doi:
Types de publication
Case Reports
Langues
eng
Pagination
756014Informations de copyright
Copyright © 2021 Knoflach, Holzapfel, Roser, Rudolph, Paolini, Muenchhoff, Osterman, Griese, Kappler and von Both.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):596-608
pubmed: 32840614
Eur J Neurol. 2021 Nov;28(11):3856-3865
pubmed: 34339563
Br Ir Orthopt J. 2021 Jan 18;17(1):8-12
pubmed: 34278212
Lancet Neurol. 2021 Mar;20(3):169-170
pubmed: 33609467
Radiol Case Rep. 2021 Jun;16(6):1400-1404
pubmed: 33824691
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998
pubmed: 32167747
J Trop Pediatr. 2021 Jul 2;67(3):
pubmed: 32910826
J AAPOS. 2020 Aug;24(4):216-217
pubmed: 32592761
J AAPOS. 2021 Jun;25(3):169-170
pubmed: 33689910
N Engl J Med. 2010 Aug 26;363(9):891-3
pubmed: 20818852
J Int Med Res. 2021 Jan;49(1):300060520986702
pubmed: 33445999
Lancet Child Adolesc Health. 2021 Mar;5(3):167-177
pubmed: 33338439
Eur J Neurol. 2000 Mar;7(2):145-9
pubmed: 10809934
Clin Ophthalmol. 2017 Oct 30;11:1917-1930
pubmed: 29133973
BMC Infect Dis. 2012 Apr 30;12:105
pubmed: 22545865
BMJ. 2009 Sep 07;339:b3354
pubmed: 19736282
Neurosci Lett. 2021 Jan 19;743:135567
pubmed: 33352286
Pediatr Neurol. 2021 Jul;120:11
pubmed: 33962343
Clin Microbiol Infect. 2021 Sep;27(9):1207-1211
pubmed: 33813108
Case Rep Pediatr. 2015;2015:734516
pubmed: 26257972
Pediatr Neurol. 2021 Feb;115:48-49
pubmed: 33333460
Brain Dev. 2021 Feb;43(2):357-359
pubmed: 32950319
Pediatr Emerg Care. 2016 May;32(5):307-11
pubmed: 25806679
Eur J Neurol. 2020 Aug;27(8):1578-1587
pubmed: 32416028
Am J Ophthalmol. 2006 Nov;142(5):827-34
pubmed: 16989758
Ital J Pediatr. 2021 Jun 2;47(1):123
pubmed: 34078441
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
J Neurovirol. 2021 Feb;27(1):171-177
pubmed: 33460014
Pediatr Infect Dis J. 2020 Oct;39(10):e332-e334
pubmed: 32826723